253 reports of this reaction
3.1% of all PROPYLENE GLYCOL reports
#5 most reported adverse reaction
OCULAR HYPERAEMIA is the #5 most commonly reported adverse reaction for PROPYLENE GLYCOL, manufactured by Alcon Laboratories, Inc.. There are 253 FDA adverse event reports linking PROPYLENE GLYCOL to OCULAR HYPERAEMIA. This represents approximately 3.1% of all 8,103 adverse event reports for this drug.
Patients taking PROPYLENE GLYCOL who experience ocular hyperaemia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
OCULAR HYPERAEMIA is moderately reported among PROPYLENE GLYCOL users, representing a notable but not dominant share of adverse events.
In addition to ocular hyperaemia, the following adverse reactions have been reported for PROPYLENE GLYCOL:
The following drugs have also been linked to ocular hyperaemia in FDA adverse event reports:
OCULAR HYPERAEMIA has been reported as an adverse event in 253 FDA reports for PROPYLENE GLYCOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
OCULAR HYPERAEMIA accounts for approximately 3.1% of all adverse event reports for PROPYLENE GLYCOL, making it a notable side effect.
If you experience ocular hyperaemia while taking PROPYLENE GLYCOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.